GHK-Cu copper peptides for hair growth: hype vs. evidence

What did @alexfinken actually say?

About six weeks after a hair transplant, @alexfinken called GHK-Cu copper peptides "one of the most groundbreaking ingredients you can buy over the counter" for scalp and hair growth. He credited the peptide with repairing damaged follicles, extending the anagen (growth) phase, and rebuilding collagen in scalp tissue. He also said he uses it alongside minoxidil and mentioned a specific brand called Fleur, noting he receives a commission on sales, though the price is the same either way. That last bit of transparency is genuinely refreshing on TikTok.

He did not make any extreme medical claims. He described GHK-Cu as a supportive topical, not a cure, and framed it as one tool among several. That framing matters when evaluating whether the underlying science holds up.

Does the science back this up?

Partly, yes. The evidence for GHK-Cu on hair follicles is real, but it is mostly preclinical. Do not mistake animal and cell studies for proven human outcomes.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has been studied since the 1970s, largely through the work of Loren Pickart. A 1993 paper by Uno and Kurata published in the Journal of Investigative Dermatology found that topical GHK-Cu stimulated hair follicle growth in macaques. A 2018 review by Pickart, Vasquez-Soltero, and Margolina in the journal Biomolecules summarized evidence that GHK-Cu promotes collagen synthesis, activates antioxidant pathways, and may influence follicle cycling. Human randomized controlled trial data, however, is sparse. One small human study compared GHK-Cu to minoxidil 2% for androgenetic alopecia and found comparable results, but sample sizes were limited. The collagen and tissue repair claims have more support in wound healing literature than in scalp-specific research.

What did they get wrong (or right)?

The follicle repair and collagen claims are directionally accurate based on existing research, though presented with more confidence than the human data warrants. The anagen-extension claim is where things get shakier.

Saying GHK-Cu will "extend the growth phase, which means less shedding and more growth" sounds mechanistically clean, but the evidence for this specific effect in humans post-transplant is essentially nonexistent. Transplanted grafts go through a predictable shock loss phase driven by surgical trauma and follicular stress, not primarily by collagen deficiency. A copper peptide serum is unlikely to meaningfully override that biology. Overstating what a topical can do in the weeks immediately after a hair transplant is a real problem, especially for a viewer who might deprioritize physician-recommended post-op protocols in favor of a serum.

He did correctly note compatibility with minoxidil, which is supported by the literature. He also disclosed his affiliate relationship clearly, which many creators skip entirely.

What should you actually know?

GHK-Cu is a legitimate bioactive peptide with a real body of preclinical research behind it. It is not snake oil. But the gap between "interesting preclinical signal" and "proven hair growth therapy" is large, and @alexfinken does not acknowledge that gap at all.

If you have recently had a hair transplant, your post-op protocol should be dictated by your surgeon, not by a TikTok topical recommendation. Post-transplant care is a medical matter. The standard of care typically involves finasteride or dutasteride evaluation, minoxidil, and in some practices PRP or low-level laser therapy, all of which have more robust evidence than copper peptides in the post-surgical setting.

For people with androgenetic alopecia who have not had surgery, GHK-Cu as a supplementary topical is a reasonable low-risk option to explore, ideally under clinical guidance. It is not a replacement for FDA-approved treatments. The multi-peptide blend in the Fleur product is marketed as additive, but synergistic effects of stacked peptides have not been studied in controlled trials.

Is there anything the video missed entirely?

Yes. No mention of concentration, which matters significantly. Most studied formulations use GHK-Cu at 0.1% to 2%. Consumer products vary widely and rarely disclose exact concentrations. Without knowing what concentration is in the product being used, the science cited is only loosely applicable. Additionally, some individuals experience scalp irritation or copper sensitivity with topical peptide formulations, which was not mentioned. Anyone with a compromised scalp barrier post-transplant should be especially cautious about introducing new actives without medical sign-off.